Literature DB >> 19222725

Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS).

Margaret J Blayney1, Francesca Tentori.   

Abstract

The Dialysis Outcomes and Practice Patterns Study (DOPPS), an ongoing observational study of haemodialysis (HD) patients, practices and outcomes in 12 countries, provides detailed data on chronic kidney disease-mineral bone disorder and related outcomes. This paper describes international trends in serum phosphorus, calcium and parathyroid hormone (PTH) levels over the past 10 years and reviews DOPPS findings on the relationship between mortality (all-cause and cardiovascular) and levels of serum phosphorus, calcium, PTH and alkaline phosphatase (AP). In addition, the DOPPS has shown how abnormal levels of these mineral metabolism indicators are associated with increased risk of certain clinical outcomes, including parathyroidectomies, fractures and pruritus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222725     DOI: 10.1111/j.1755-6686.2009.00048.x

Source DB:  PubMed          Journal:  J Ren Care        ISSN: 1755-6678


  7 in total

1.  Multidisciplinary Team versus a "Phosphate-Counting" App for Serum Phosphate Control: A Randomized Controlled Trial.

Authors:  Ana Cecilia Farfan-Ruiz; Daniel Czikk; Julie Leidecker; Tim Ramsay; Brendan McCormick; Kumanan Wilson; Deborah Zimmerman
Journal:  Kidney360       Date:  2020-12-15

2.  Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis.

Authors:  Steven Fishbane; Azzour D Hazzan; Kenar D Jhaveri; Lin Ma; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 8.237

3.  Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States.

Authors:  Sumi Sukumaran Nair; Aya A Mitani; Benjamin A Goldstein; Glenn M Chertow; David W Lowenberg; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

4.  Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis.

Authors:  Evan W Davies; Louis S Matza; Gavin Worth; David H Feeny; Jacqueline Kostelec; Steven Soroka; David Mendelssohn; Philip McFarlane; Vasily Belozeroff
Journal:  Health Qual Life Outcomes       Date:  2015-06-30       Impact factor: 3.186

5.  Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.

Authors:  Rameez Imtiaz; Steven Hawken; Brendan B McCormick; Simon Leung; Swapnil Hiremath; Deborah L Zimmerman
Journal:  Nutrients       Date:  2017-02-17       Impact factor: 5.717

6.  Fracture risk in dialysis and kidney transplanted patients: a protocol for systematic review and meta-analysis.

Authors:  Aboubacar Sidibé; Lynne Moore; Sonia Jean; Fabrice Mac-Way
Journal:  Syst Rev       Date:  2017-02-22

7.  Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.

Authors:  Simon Leung; Brendan McCormick; Jessica Wagner; Mohan Biyani; Susan Lavoie; Rameez Imtiaz; Deborah Zimmerman
Journal:  BMC Nephrol       Date:  2015-12-09       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.